33 related articles for article (PubMed ID: 38464491)
1. Lopinavir/ritonavir: a review of its use in the management of HIV infection.
Cvetkovic RS; Goa KL
Drugs; 2003; 63(8):769-802. PubMed ID: 12662125
[TBL] [Abstract][Full Text] [Related]
2. REVIEW OF CONTROL OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN NIGERIA.
Dami N; Shehu NY; Dami S; Iroezindu MO
Niger J Med; 2015; 24(3):281-6. PubMed ID: 27487603
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment and Acquired Drug Resistance in Children With Human Immunodeficiency Virus Type 1 in Jos, Nigeria.
Ebonyi AO; Okpokwu J; Rawizza H; Chebu P; Chaplin B; Hamel D; Oguche S; Agbaji OO; Sagay AS; Kanki PJ; Imade GE
Open Forum Infect Dis; 2024 Mar; 11(3):ofae092. PubMed ID: 38464491
[TBL] [Abstract][Full Text] [Related]
4. Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails.
Sungkanuparph S; Manosuthi W; Kiertiburanakul S; Piyavong B; Chumpathat N; Chantratita W
Clin Infect Dis; 2007 Feb; 44(3):447-52. PubMed ID: 17205457
[TBL] [Abstract][Full Text] [Related]
5. Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapy.
Svärd J; Mugusi S; Mloka D; Neogi U; Meini G; Mugusi F; Incardona F; Zazzi M; Sönnerborg A
PLoS One; 2017; 12(6):e0178942. PubMed ID: 28582463
[TBL] [Abstract][Full Text] [Related]
6. Short communication: east meets west: a description of HIV-1 drug resistance mutation patterns of patients failing first line therapy in PEPFAR clinics from Uganda and Nigeria.
Crawford KW; Wakabi S; Kibuuka H; Magala F; Keshinro B; Okoye I; Akintunde E; Hamm TE
AIDS Res Hum Retroviruses; 2014 Aug; 30(8):796-9. PubMed ID: 24798614
[TBL] [Abstract][Full Text] [Related]
7. High Prevalence of HIV Drug Resistance Among Newly Diagnosed Infants Aged <18 Months: Results From a Nationwide Surveillance in Nigeria.
Inzaule SC; Osi SJ; Akinbiyi G; Emeka A; Khamofu H; Mpazanje R; Ilesanmi O; Ndembi N; Odafe S; Sigaloff KCE; Rinke de Wit TF; Akanmu S
J Acquir Immune Defic Syndr; 2018 Jan; 77(1):e1-e7. PubMed ID: 28961680
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment HIV drug resistance increases regimen switches in sub-Saharan Africa.
Boender TS; Hoenderboom BM; Sigaloff KC; Hamers RL; Wellington M; Shamu T; Siwale M; Labib Maksimos EE; Nankya I; Kityo CM; Adeyemo TA; Akanmu AS; Mandaliya K; Botes ME; Ondoa P; Rinke de Wit TF
Clin Infect Dis; 2015 Dec; 61(11):1749-58. PubMed ID: 26240203
[TBL] [Abstract][Full Text] [Related]
9. Alarming increase in pretreatment HIV drug resistance in children living in sub-Saharan Africa: a systematic review and meta-analysis.
Boerma RS; Sigaloff KC; Akanmu AS; Inzaule S; Boele van Hensbroek M; Rinke de Wit TF; Calis JC
J Antimicrob Chemother; 2017 Feb; 72(2):365-371. PubMed ID: 27999070
[TBL] [Abstract][Full Text] [Related]
10. High levels of pre-treatment HIV drug resistance and treatment failure in Nigerian children.
Boerma RS; Boender TS; Sigaloff KC; Rinke de Wit TF; van Hensbroek MB; Ndembi N; Adeyemo T; Temiye EO; Osibogun A; Ondoa P; Calis JC; Akanmu AS
J Int AIDS Soc; 2016; 19(1):21140. PubMed ID: 27836020
[TBL] [Abstract][Full Text] [Related]
11. Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa.
Boender TS; Kityo CM; Boerma RS; Hamers RL; Ondoa P; Wellington M; Siwale M; Nankya I; Kaudha E; Akanmu AS; Botes ME; Steegen K; Calis JC; Rinke de Wit TF; Sigaloff KC
J Antimicrob Chemother; 2016 Oct; 71(10):2918-27. PubMed ID: 27342546
[TBL] [Abstract][Full Text] [Related]
12. The development of drug resistance mutations K103N Y181C and G190A in long term Nevirapine-containing antiviral therapy.
Wang Y; Xing H; Liao L; Wang Z; Su B; Zhao Q; Feng Y; Ma P; Liu J; Wu J; Ruan Y; Shao Y
AIDS Res Ther; 2014; 11():36. PubMed ID: 25926857
[TBL] [Abstract][Full Text] [Related]
13. Drug resistance in the HIV-1-infected paediatric population worldwide: a systematic review.
Rojas Sánchez P; Holguín A
J Antimicrob Chemother; 2014 Aug; 69(8):2032-42. PubMed ID: 24788658
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral resistance in HIV-infected Saudi children failing first-line highly active antiretroviral therapy.
Al Hajjar SH; Frayha H; Althawadi S
Ann Saudi Med; 2012; 32(6):565-9. PubMed ID: 23396017
[TBL] [Abstract][Full Text] [Related]
15. Antiviral resistance and correlates of virologic failure in the first cohort of HIV-infected children gaining access to structured antiretroviral therapy in Lima, Peru: a cross-sectional analysis.
Rath BA; von Kleist M; Castillo ME; Kolevic L; Caballero P; Soto-Castellares G; Amedee AM; Robinson JE; Katzenstein DK; Van Dyke RB; Oberhelman RA
BMC Infect Dis; 2013 Jan; 13():1. PubMed ID: 23280237
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
